5 results match your criteria: "*Surgical Dermatology and Laser Center[Affiliation]"
Penile Squamous Cell Carcinoma: Penis-Preserving Treatment With Mohs Micrographic Surgery.
Dermatol Surg
August 2016
*Surgical Dermatology and Laser Center, Las Vegas, Nevada; †Zitelli & Brodland, PC, Pittsburgh, Pennsylvania.
Background: There have been few published case series of penile squamous cell carcinoma (SCC) removed with Mohs micrographic surgery (MMS). Of these case series, the published cure rates are between 68% and 74%.
Objective: To report 30 years of experience removing penile SCCs with MMS.
Reply: "Unnecessarily Undergeneralizing Data"-Dermatol Surg 2016;775.
Dermatol Surg
June 2016
Surgical Dermatology and Laser Center, Las Vegas, Nevada Zitelli and Brodland, PC, Pittsburgh, Pennsylvania.
Effectiveness and Advantages of On-Site Pathology Services in the Care of Patients With Nonmelanoma Skin Cancer.
Dermatol Surg
January 2016
*Surgical Dermatology and Laser Center, Las Vegas, Nevada; †Zitelli & Brodland, PC, Shadyside Medical Building, Pittsburgh, Pennsylvania.
Background: On-site pathology services are an integral part of many dermatology and surgical dermatology practices in the United States.
Objective: Assess the effectiveness and advantages of on-site pathology services.
Methods: Biopsy data from 7 practices with on-site pathology services were reviewed to determine the diagnostic accuracy of malignancies from all lesional biopsies.
Active ascertainment of recurrence rate after treatment of primary basal cell carcinoma (BCC).
J Am Acad Dermatol
August 2015
DuPage Medical Group, Naperville, Illinois.
Alternative techniques for reduction of scar length during staged excision.
J Am Acad Dermatol
October 2011
Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois; Department of Otolaryngology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois; Department of Surgery, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.
Background: Staged excision is routinely used to remove disfiguring or premalignant cutaneous lesions with reduced functional loss or patient debilitation. Conventional staged excision results in a final scar length that is significantly shorter than the scar associated with a traditional elliptical excision with a 3:1 length to width ratio.
Objective: We describe alternatives to the conventional staged excision that enable even further reduction in final scar length.